Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2025-12-24 @ 3:50 PM
NCT ID:
NCT05290792
Eligibility Criteria:
Inclusion Criteria:
* Men or women aged 18-59 years
* Did not receive the 2021-2022 seasonal influenza vaccine
* Not planning to get another vaccine during the 14-day observation period.
Exclusion Criteria:
* PCR-confirmed VRTI at screening
* Any infectious symptoms (fever, cough, rhinorrhea, sore throat, diarrhea, loss of smell or taste) within the previous 7 days
* Any chronic medical condition;
* Obesity (BMI\>35 kg/m2);
* Any prescription drug other than oral contraceptives or routine and stable dose medications;
* Contraindication to LAIV
* Current smoker or ex-smoker with \>20 pack years of smoking
* Recreational drug use
* Self-reported history of substance abuse
* Pregnant or attempting to become pregnant
* Guillain-Barré syndrome (GBS) or BGS-like episode has occurred within 6 weeks of any prior influenza vaccination
* Immunocompromised
* People with severe asthma or medically attended wheezing in the 7 days prior to the proposed date of vaccination.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
59 Years
Study:
NCT05290792
Study Brief:
Protocol Section:
NCT05290792